Exclusion Criteria for Part 1:~* Treatment with another Study Drug, biological agent, or device within
one-month of Screening or 5 half-lives of investigational agent, whichever is longer~* Clinically significant
medical condition which would make the patient unsuitable for inclusion or could interfere with the patient
participating in or completing the study~* Use of a disallowed CNS-active or antipsychotic medication within 4
weeks prior to Screening punctures~Inclusion Criteria for Part 2:~* Must have completed the Treatment
Evaluation and Post-Treatment Periods in Part 1~Exclusion Criteria for Part 2 (only applicable to participants
in Cohorts A and B, as participants from Cohorts C and D will seamlessly transition to Part 2):~* Treatment
with another Study Drug, biological agent, or device within one-month of Screening or 5 half-lives of
investigational agent, whichever is longer~* Clinically significant medical condition which would make the
patient unsuitable for inclusion or could interfere with the patient participating in or completing the study~*
Use of a disallowed CNS-active or antipsychotic medication within 4 weeks prior to Screening punctures
